Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBP) Return on Sales (2016 - 2025)

Historic Return on Sales for Regen BioPharma (RGBP) over the last 11 years, with Q4 2025 value amounting to 4.28%.

  • Regen BioPharma's Return on Sales rose 44500.0% to 4.28% in Q4 2025 from the same period last year, while for Dec 2025 it was 4.28%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 5.39% for FY2025, which is 25600.0% down from last year.
  • Per Regen BioPharma's latest filing, its Return on Sales stood at 4.28% for Q4 2025, which was up 44500.0% from 9.64% recorded in Q3 2025.
  • Over the past 5 years, Regen BioPharma's Return on Sales peaked at 0.33% during Q1 2025, and registered a low of 9.64% during Q3 2025.
  • In the last 5 years, Regen BioPharma's Return on Sales had a median value of 2.18% in 2022 and averaged 3.16%.
  • In the last 5 years, Regen BioPharma's Return on Sales skyrocketed by 56900bps in 2023 and then crashed by -62700bps in 2024.
  • Over the past 5 years, Regen BioPharma's Return on Sales (Quarter) stood at 2.39% in 2021, then tumbled by -240bps to 8.15% in 2022, then skyrocketed by 70bps to 2.45% in 2023, then tumbled by -256bps to 8.73% in 2024, then surged by 51bps to 4.28% in 2025.
  • Its last three reported values are 4.28% in Q4 2025, 9.64% for Q3 2025, and 2.83% during Q2 2025.